1. Canada Stocks

  2. •

    Healthcare

  3. •

    Drug Manufacturers - Specialty & Generic
Waverunner Capital Inc.

Waverunner Capital Inc.

CHM.CN
Waverunner Capital Inc.CA flagCanadian Securities Exchange
0.05
CAD
+0.05
- -
37.21MMarket Cap
Waverunner Capital Inc.
CHM.CN
(Canadian Securities Exchange)

Recent

price

0.05

P/E

ratio

- -

div

yld

- -

ROIC.AI

2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
TTM
FRC
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
0.09
0.04
- -
- -
- -
- -
- -
Revenue per Share
-221.53
-29.06
-11.91
-8.92
-7.29
-3.76
-0.31
-1.41
-0.58
-0.38
-1.35
-1.45
-1.18
-0.64
-0.02
-0.25
-0.6
Basic EPS, GAAP
-175.09
-24.53
-11.06
-11.24
-4.33
-0.05
-2.35
-1.15
-0.52
-0.9
-1.91
-0.89
-0.65
-0.32
-0.02
-0.03
-0.06
Free Cash Flow per Basic Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Dividend per Share
-241.36
-137.25
2.73
1.42
-62.57
-65.94
-36.82
-23.2
-0.81
1.19
0.24
-1.19
-2.25
-2.31
-0.2
-0.17
-0.41
Book Value per Share
20.49
2.81
12.4
6.53
-1.73
0.11
0.77
-0.03
0.03
1.68
1.17
-0.32
-1.41
-1.43
-0.13
-0.02
-0.04
Tangible Book Value per Share
- -
- -
- -
- -
- -
- -
- -
- -
1
2
3
4
4
4
54
16
7
Basic Weighted Avg Shares
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Sales/Revenue/Turnover
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
-1,460.47
-1,575.84
- -
- -
- -
- -
- -
Operating Margin (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Depreciation Expense
-4
-1
-1
-1
-1
-1
- -
-1
-1
-1
-5
-5
-5
-3
-1
-4
-4
Net Income, GAAP
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Effective Tax Rate (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
-1,468.23
-3,386.19
- -
- -
- -
- -
- -
Profit Margin (%)
- -
- -
- -
- -
- -
1
- -
- -
- -
2
8
3
-6
2
-7
- -
- -
Working Capital
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
8
8
- -
8
- -
- -
- -
LT Debt
- -
- -
1
1
- -
- -
- -
- -
- -
3
4
-1
-5
-6
-7
- -
- -
Total Equity
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Invested Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Capital (%)
- -
- -
- -
-676.34
- -
- -
- -
- -
- -
- -
-296.71
- -
- -
- -
- -
- -
- -
Return on Common Equity (%)

Capital Structure

FRC

•

in mil. unless spec.
Dec'24
Mar'24
Jun'24
ST Debt
7
7
- -
LT Borrowings
- -
- -
- -
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
7
8
74
Market Capitalization
- -
- -
- -

Working Capital

FRC

•

in mil. unless spec.
Dec'24
Mar'24
Jun'24
Total Current Assets
- -
- -
- -
Cash, Cash Equivalents & STI
- -
- -
- -
Accounts Receivable, Net
- -
- -
- -
Inventories
- -
- -
- -
Total Current Liabilities
7
7
- -
Payables & Accruals
- -
- -
- -
ST Debt
7
7
- -
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
1,339.31%
28.82%
-96.05%
Free Cash Flow
919.36%
-41.73%
-49.55%
Net Income, GAAP
126.21%
23.68%
209.01%
Sales/Revenue/Turnover
- -
- -
- -
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2022
- -
- -
- -
- -
- -
2023
- -
- -
- -
- -
- -
2024
- -
- -
- -
- -
- -

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2022
- -
-0.18
-0.16
- -
-0.64
2023
-0.08
-0.03
-0.08
- -
-0.02
2024
-0.03
-0.02
-0.05
- -
-0.25

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2022
- -
- -
- -
- -
- -
2023
- -
- -
- -
- -
- -
2024
- -
- -
- -
- -
- -
Similar Companies
GeneFerm Biotechnology Co., Ltd. (1796.TWO)
Medicine Man Technologies, Inc. (SHWZ)
Kilitch Drugs (India) Limited (KILITCH.NS)
iAnthus Capital Holdings, Inc. (IAN.CN)
SLANG Worldwide Inc. (SLNG.CN)
RavenQuest BioMed Inc. (RVVQF)
Business
Waverunner Capital Inc. (CSE: WRUN) operates as a Canadian investment company focused on opportunistic investments across a broad range of industries, including early-stage ventures in biotechnology, renewable energy, wellness, and equity trading strategies; it provides advisory services, mentoring, and management expertise to investees. The company specializes in early-stage seed and startup financing, PIPEs, bridge financing, recapitalizations, growth capital, and secondary limited partner interests; current holdings include a consumer-targeted biotechnology venture, REVV (a renewable energy developer in wind and solar), FUEL (a plant-based wellness company), and ONLP (an Ontario limited partnership for long/short equity opportunities). Founded in 2008 and headquartered at 828 Harbourside Drive in North Vancouver, British Columbia, Waverunner targets equity investments between C$500,000 and C$1 million in companies with enterprise values of C$2 million to C$5 million across Europe and North America, funded through its balance sheet and personal capital. In June 2024, the company changed its name from Chemistree Technology Inc. to Waverunner Capital Inc.; recent developments include a proposed share consolidation approved at the November 2024 annual general and special meeting to facilitate financings and meet CSE pricing requirements, management and board changes in December 2024, a strategic non-brokered private placement of up to 4.9 million shares at C$0.05 in late 2024, and first-quarter earnings reported for the period ended September 30, 2025.